Bolt Biotherapeutics, Inc. (BOLT)
6.27
+2.08
(+49.64%)
USD |
NASDAQ |
Oct 23, 16:00
6.66
+0.39
(+6.22%)
Pre-Market: 08:38
Bolt Biotherapeutics Market Cap : 12.08M for Oct. 23, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 23, 2026 | 12.08M |
| October 22, 2026 | 8.071M |
| October 21, 2026 | 7.975M |
| October 20, 2026 | 8.302M |
| October 19, 2026 | 7.782M |
| October 16, 2026 | 7.705M |
| October 15, 2026 | 8.168M |
| October 14, 2026 | 7.667M |
| October 13, 2026 | 8.254M |
| October 12, 2026 | 8.168M |
| October 09, 2026 | 7.917M |
| October 08, 2026 | 7.031M |
| October 07, 2026 | 6.935M |
| October 06, 2026 | 6.761M |
| October 05, 2026 | 6.740M |
| October 02, 2026 | 6.646M |
| October 01, 2026 | 6.761M |
| September 30, 2026 | 7.089M |
| September 29, 2026 | 6.935M |
| September 28, 2026 | 6.665M |
| September 25, 2026 | 6.896M |
| September 24, 2026 | 6.915M |
| September 23, 2026 | 7.031M |
| September 22, 2026 | 7.147M |
| September 21, 2026 | 6.915M |
| Date | Value |
|---|---|
| September 18, 2026 | 6.858M |
| September 17, 2026 | 6.444M |
| September 16, 2026 | 6.992M |
| September 15, 2026 | 7.763M |
| September 14, 2026 | 7.667M |
| September 11, 2026 | 7.609M |
| September 10, 2026 | 7.185M |
| September 09, 2026 | 7.085M |
| September 08, 2026 | 7.436M |
| September 04, 2026 | 7.513M |
| September 03, 2026 | 7.503M |
| September 02, 2026 | 7.397M |
| September 01, 2026 | 7.84M |
| August 31, 2026 | 7.667M |
| August 28, 2026 | 7.349M |
| August 27, 2026 | 7.705M |
| August 26, 2026 | 7.551M |
| August 25, 2026 | 7.416M |
| August 24, 2026 | 7.204M |
| August 21, 2026 | 7.060M |
| August 20, 2026 | 6.164M |
| August 19, 2026 | 6.280M |
| August 18, 2026 | 6.121M |
| August 17, 2026 | 6.164M |
| August 14, 2026 | 6.453M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 8.189B |
| Oncolytics Biotech, Inc. | 62.61M |
| Sangamo Therapeutics, Inc. | 47.64M |
| Sarepta Therapeutics, Inc. | 1.873B |
| Anixa Biosciences, Inc. | 103.41M |
Market Cap Related Metrics
| PS Ratio | 2.340 |
| PEG Ratio | -0.0173 |
| Price to Book Value | 0.9555 |
| Price | 6.27 |
| Earnings Yield | -262.2% |
| PEGY Ratio | -0.0173 |